Skyhook

Skyhook accelerates the discovery and development of differentiated therapeutics by accessing vast biological design spaces previously intractable with current state of the art technologies. Our differentiated platform employs efficient AI-guided design, synthesis, and functional screening of diverse programmable biomolecule libraries at unprecedented speed and scale. Skyhook is an RA Ventures* company. *RA Ventures is the venture focused division of RA Capital Management.